ALT logo

Altimmune (ALT) Revenue

Annual Revenue

$20.00 K
-$406.00 K-95.31%

December 31, 2024


Summary


Performance

ALT Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALTprofitabilitymetrics:

Quarterly Revenue

$5000.00
$0.000.00%

December 31, 2024


Summary


Performance

ALT Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$20.00 K
-$32.00 K-61.54%

December 31, 2024


Summary


Performance

ALT TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALTprofitabilitymetrics:

ALT Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.3%-86.5%-95.3%
3 y3 years-99.5%-99.8%-99.5%
5 y5 years-99.7%-99.1%-99.7%

ALT Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.5%+129.4%-99.8%+104.5%-99.5%+124.7%
5 y5-year-99.8%+129.4%-99.8%+104.5%-99.8%+124.7%
alltimeall time-99.9%+129.4%-100.0%+104.5%-99.9%+124.7%

Altimmune Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$20.00 K(-95.3%)
$5000.00(0.0%)
$20.00 K(-61.5%)
Sep 2024
-
$5000.00(0.0%)
$52.00 K(-87.3%)
Jun 2024
-
$5000.00(0.0%)
$409.00 K(-0.2%)
Mar 2024
-
$5000.00(-86.5%)
$410.00 K(-3.8%)
Dec 2023
$426.00 K(-726.5%)
$37.00 K(-89.8%)
$426.00 K(+52.7%)
Sep 2023
-
$362.00 K(+5933.3%)
$279.00 K(-444.4%)
Jun 2023
-
$6000.00(-71.4%)
-$81.00 K(+2.5%)
Mar 2023
-
$21.00 K(-119.1%)
-$79.00 K(+16.2%)
Dec 2022
-$68.00 K(-101.5%)
-$110.00 K(-5600.0%)
-$68.00 K(-102.0%)
Sep 2022
-
$2000.00(-75.0%)
$3.32 M(-4.5%)
Jun 2022
-
$8000.00(-75.0%)
$3.48 M(-3.6%)
Mar 2022
-
$32.00 K(-99.0%)
$3.60 M(-18.3%)
Dec 2021
$4.41 M(-46.1%)
$3.28 M(+1974.1%)
$4.41 M(+28.0%)
Sep 2021
-
$158.00 K(+15.3%)
$3.45 M(-44.7%)
Jun 2021
-
$137.00 K(-83.7%)
$6.23 M(-8.6%)
Mar 2021
-
$838.00 K(-63.8%)
$6.81 M(-16.8%)
Dec 2020
$8.19 M(+41.1%)
$2.31 M(-21.3%)
$8.19 M(+26.9%)
Sep 2020
-
$2.94 M(+307.2%)
$6.45 M(+55.2%)
Jun 2020
-
$721.60 K(-67.4%)
$4.15 M(-17.9%)
Mar 2020
-
$2.21 M(+284.3%)
$5.06 M(-12.8%)
Dec 2019
$5.80 M(-43.8%)
$575.80 K(-10.6%)
$5.80 M(-25.8%)
Sep 2019
-
$644.00 K(-60.4%)
$7.81 M(-20.3%)
Jun 2019
-
$1.63 M(-45.0%)
$9.80 M(-7.5%)
Mar 2019
-
$2.96 M(+14.2%)
$10.60 M(+2.6%)
Dec 2018
$10.33 M(-3.8%)
$2.59 M(-1.7%)
$10.33 M(-44.0%)
Sep 2018
-
$2.63 M(+9.0%)
$18.44 M(+16.5%)
Jun 2018
-
$2.42 M(-10.2%)
$15.84 M(+18.0%)
Mar 2018
-
$2.69 M(-74.9%)
$13.42 M(+25.0%)
Dec 2017
$10.74 M(+2518.5%)
$10.70 M(>+9900.0%)
$10.74 M(+3758.5%)
Sep 2017
-
$26.70 K(+444.9%)
$278.30 K(+8.5%)
Jun 2017
-
$4900.00(0.0%)
$256.50 K(-37.5%)
Mar 2017
-
$4900.00(-98.0%)
$410.10 K(-70.9%)
Dec 2016
$410.10 K(-96.1%)
$241.80 K(+4834.7%)
$1.41 M(-42.1%)
Sep 2016
-
$4900.00(-96.9%)
$2.44 M(-32.1%)
Jun 2016
-
$158.50 K(-84.2%)
$3.59 M(-21.7%)
Mar 2016
-
$1.01 M(-20.6%)
$4.58 M(-57.0%)
Dec 2015
$10.64 M
$1.27 M(+9.6%)
$10.64 M(-5.0%)
Sep 2015
-
$1.16 M(+0.5%)
$11.20 M(+1.8%)
Jun 2015
-
$1.15 M(-83.7%)
$11.01 M(-18.6%)
DateAnnualQuarterlyTTM
Mar 2015
-
$7.07 M(+287.1%)
$13.52 M(+32.6%)
Dec 2014
$10.19 M(-43.1%)
$1.83 M(+89.7%)
$10.19 M(-15.2%)
Sep 2014
-
$962.50 K(-73.7%)
$12.02 M(-17.4%)
Jun 2014
-
$3.66 M(-2.2%)
$14.54 M(-4.2%)
Mar 2014
-
$3.74 M(+2.4%)
$15.18 M(-15.3%)
Dec 2013
$17.91 M(-28.9%)
$3.65 M(+4.8%)
$17.91 M(-11.6%)
Sep 2013
-
$3.49 M(-18.8%)
$20.27 M(-13.7%)
Jun 2013
-
$4.30 M(-33.7%)
$23.48 M(-7.9%)
Mar 2013
-
$6.48 M(+7.7%)
$25.50 M(+1.3%)
Dec 2012
$25.18 M(+3.7%)
$6.01 M(-10.2%)
$25.18 M(-0.9%)
Sep 2012
-
$6.70 M(+6.0%)
$25.40 M(+6.0%)
Jun 2012
-
$6.32 M(+2.7%)
$23.97 M(-0.5%)
Mar 2012
-
$6.15 M(-1.5%)
$24.08 M(-0.8%)
Dec 2011
$24.27 M(+15.6%)
$6.24 M(+18.6%)
$24.27 M(-2.5%)
Sep 2011
-
$5.26 M(-18.2%)
$24.88 M(-3.8%)
Jun 2011
-
$6.43 M(+1.4%)
$25.86 M(+6.8%)
Mar 2011
-
$6.34 M(-7.5%)
$24.21 M(+15.3%)
Dec 2010
$20.99 M(-23.8%)
$6.85 M(+9.8%)
$20.99 M(-1.3%)
Sep 2010
-
$6.24 M(+30.6%)
$21.27 M(-2.7%)
Jun 2010
-
$4.78 M(+53.4%)
$21.85 M(-13.1%)
Mar 2010
-
$3.12 M(-56.3%)
$25.14 M(-8.7%)
Dec 2009
$27.55 M(-16.3%)
$7.13 M(+4.3%)
$27.55 M(+6.4%)
Sep 2009
-
$6.83 M(-15.4%)
$25.90 M(-12.9%)
Jun 2009
-
$8.07 M(+46.2%)
$29.75 M(-8.7%)
Mar 2009
-
$5.52 M(+0.8%)
$32.59 M(-1.0%)
Dec 2008
$32.91 M(+124.7%)
$5.48 M(-48.7%)
$32.91 M(-1.4%)
Sep 2008
-
$10.68 M(-2.2%)
$33.39 M(+28.0%)
Jun 2008
-
$10.91 M(+86.9%)
$26.09 M(+49.7%)
Mar 2008
-
$5.84 M(-2.1%)
$17.42 M(+19.7%)
Dec 2007
$14.64 M(+780.4%)
$5.96 M(+76.8%)
$14.55 M(+44.6%)
Sep 2007
-
$3.37 M(+50.0%)
$10.06 M(+50.4%)
Jun 2007
-
$2.25 M(-24.3%)
$6.69 M(+36.3%)
Mar 2007
-
$2.97 M(+101.2%)
$4.91 M(+109.2%)
Dec 2006
$1.66 M(+183.8%)
$1.48 M(>+9900.0%)
$2.35 M(+87.5%)
Sep 2006
-
$1600.00(-99.7%)
$1.25 M(-14.0%)
Jun 2006
-
$466.00 K(+15.1%)
$1.46 M(+47.0%)
Mar 2006
-
$405.00 K(+6.6%)
$991.10 K(+69.1%)
Dec 2005
$586.10 K
$379.80 K(+84.1%)
$586.10 K(+184.1%)
Sep 2005
-
$206.30 K
$206.30 K

FAQ

  • What is Altimmune annual revenue?
  • What is the all time high annual revenue for Altimmune?
  • What is Altimmune annual revenue year-on-year change?
  • What is Altimmune quarterly revenue?
  • What is the all time high quarterly revenue for Altimmune?
  • What is Altimmune quarterly revenue year-on-year change?
  • What is Altimmune TTM revenue?
  • What is the all time high TTM revenue for Altimmune?
  • What is Altimmune TTM revenue year-on-year change?

What is Altimmune annual revenue?

The current annual revenue of ALT is $20.00 K

What is the all time high annual revenue for Altimmune?

Altimmune all-time high annual revenue is $32.91 M

What is Altimmune annual revenue year-on-year change?

Over the past year, ALT annual revenue has changed by -$406.00 K (-95.31%)

What is Altimmune quarterly revenue?

The current quarterly revenue of ALT is $5000.00

What is the all time high quarterly revenue for Altimmune?

Altimmune all-time high quarterly revenue is $10.91 M

What is Altimmune quarterly revenue year-on-year change?

Over the past year, ALT quarterly revenue has changed by -$32.00 K (-86.49%)

What is Altimmune TTM revenue?

The current TTM revenue of ALT is $20.00 K

What is the all time high TTM revenue for Altimmune?

Altimmune all-time high TTM revenue is $33.39 M

What is Altimmune TTM revenue year-on-year change?

Over the past year, ALT TTM revenue has changed by -$406.00 K (-95.31%)